Managing perioperative neurocognitive disorders in geriatric patients: past, present, and future Authors: Sarah Saxena, Yotam Weiss, Thomas Saller Published: 2025 ABSTRACT AbstractNeurocognitive disorders remain one of the tricky perioperative complications, despite progress in screening tools and care bundles. BMC Anesthesiology has initiated a new collection on managing perioperative neurocognitive disorders in the geriatric patient, urging researchers to conduct large-scale, high-quality studies that address the existing knowledge and implementation gap. Introduction As anesthesiologists, we have every reason to be proud of our role in reducing short-term outcomes such as perioperative morbidity and mortality through a commitment to patient safety and multidisciplinary collaboration. We anesthesiologists are the ones who made modern surgery possible: Difficult and invasive surgery or even transplantation are unthinkable without an anesthesiologist’s skills in airway management, modern general and regional anesthesia regimens, advanced monitoring and hemodynamic support. So are procedures in every patient group from neonates to octogenarians. Yet perioperative neurocognitive disorders (NCD) remind us that survival is not the only outcome that matters. Perioperative cognitive impairment remains among the trickiest complications for patients and families, especially in older surgical candidates [1]. It is associated with loss of independence, institutionalization, and reduced quality of life – outcomes our patients value as much as, if not more than, survival itself [2, 3]. Despite decades of recognition, perioperative NCD remain inconsistently prevented, underdiagnosed, and insufficiently prioritized. If the last century was about keeping patients alive, the next must be about ensuring they retain their cognitive selves. The past: a history of under-recognition In 1887, George Savage was the first to write a case report on ‘perioperative insanity’ [4]. Since then, perioperative cognitive changes have been dismissed as part of ‘normal aging’ or attributed to surgical stress. Only in the 1990’s did the scale of perioperative NCD become evident: up to one in four older adults experienced measurable cognitive decline three months after non-cardiac surgery [2]. Even then, lack of standardized definitions and heterogeneous testing delayed progress (Fig. 1). Managing Perioperative Neurocognitive Disorders: past, present, and future The present: structured recognition, partial solutions The 2018 consensus redefining nomenclature and introducing perioperative NCD was a turning point, providing a unifying framework [5]. Simplified, we can now recognize delirium as a distinct, acute syndrome; delayed recovery as transient; and longer-term cognitive dysfunction as persistent impairment. With this clarity, we can finally compare data across studies and build cumulative knowledge. Today, perioperative NCD management includes strategies such as: Risk stratification. Preoperative cognitive and frailty assessment can identify high-risk patients, but implementation remains patchy. Few centers perform routine screening [5]. Risk stratification. Preoperative cognitive and frailty assessment can identify high-risk patients, but implementation remains patchy. Few centers perform routine screening [5]. Intraoperative optimization. Depth of anesthesia monitoring and multimodal regimens (including loco-regional anesthesia techniques) seem to reduce delirium risk. Yet evidence remains mixed, and practice varies widely. Intraoperative optimization. Depth of anesthesia monitoring and multimodal regimens (including loco-regional anesthesia techniques) seem to reduce delirium risk. Yet evidence remains mixed, and practice varies widely. Postoperative care. Delirium-prevention bundles, early mobilization, and orientation strategies are increasingly embedded in ERAS protocols and society endorsed [6, 7]. Postoperative care. Delirium-prevention bundles, early mobilization, and orientation strategies are increasingly embedded in ERAS protocols and society endorsed [6, 7]. However, resource limitations and variable compliance hinder widespread adoption. While we can acknowledge progress since 1887, the reality today is also sobering: perioperative NCD still affect a substantial proportion of surgical patients, and outcomes remain poor. The screening tools exist, but their translation into everyday anesthetic practice lags behind. The future: precision neuroprotection To move forward, we must embrace innovation while also confronting inertia. Several opportunities are on the horizon: Biomarkers. Recent examined biomarkers are too unspecific to be useful in daily practice. Blood-based measures of inflammatory cytokines, neurodegeneration and -damage (such as p-tau, Nf-L and HMGB1) may enable individualized risk prediction but require validation and integration into workflows [8, 9]. Biomarkers. Recent examined biomarkers are too unspecific to be useful in daily practice. Blood-based measures of inflammatory cytokines, neurodegeneration and -damage (such as p-tau, Nf-L and HMGB1) may enable individualized risk prediction but require validation and integration into workflows [8, 9]. Advanced monitoring. Functional neuroimaging and EEG analytics could personalize anesthetic depth and identify vulnerable brain networks in real time [10]. However, we should not expect miracles - individualized hemodynamic management for example has not improved outcomes in the POISE-3 trial [11]. Advanced monitoring. Functional neuroimaging and EEG analytics could personalize anesthetic depth and identify vulnerable brain networks in real time [10]. However, we should not expect miracles - individualized hemodynamic management for example has not improved outcomes in the POISE-3 trial [11]. Pharmacological strategies. Agents targeting neuroinflammation (e.g., dexmedetomidine, statins, biologics) are promising but need large, pragmatic trials [12]. Pharmacological strategies. Agents targeting neuroinflammation (e.g., dexmedetomidine, statins, biologics) are promising but need large, pragmatic trials [12]. Digital cognitive tools. Tablet-based screening platforms, preoperative cognitive exercise programs, and artificial intelligence (AI) driven predictive models may have the potential to integrate routine perioperative cognitive monitoring into everyday clinical practice [13]. Digital cognitive tools. Tablet-based screening platforms, preoperative cognitive exercise programs, and artificial intelligence (AI) driven predictive models may have the potential to integrate routine perioperative cognitive monitoring into everyday clinical practice [13]. Prehabilitation and Rehabilitation. Cognitive training and structured recovery programs should be embedded into ERAS, with outcomes measured not only in length of stay or need for care but also in cognitive trajectories. Prehabilitation and Rehabilitation. Cognitive training and structured recovery programs should be embedded into ERAS, with outcomes measured not only in length of stay or need for care but also in cognitive trajectories. A call to action The trajectory of perioperative NCD research reflects anesthesiology’s broader evolution -allowing our patients not only to survive, but to maintain what matters most. Our specialty has an ethical obligation to protect not only hearts and lungs but also minds. To achieve this, three priorities stand out: Universal screening. Just as no patient undergoes surgery without cardiovascular risk assessment, no older adult should enter the operating room without cognitive risk evaluation and frailty assessment. Universal screening. Just as no patient undergoes surgery without cardiovascular risk assessment, no older adult should enter the operating room without cognitive risk evaluation and frailty assessment. Implementation science. Proven interventions—non-pharmacological delirium-prevention bundles—must be adopted widely. Journals and professional societies should emphasize implementation, not just discovery. Implementation science. Proven interventions—non-pharmacological delirium-prevention bundles—must be adopted widely. Journals and professional societies should emphasize implementation, not just discovery. Patient-centered outcomes. Future trials should measure independence, functional recovery, and quality of life, not just neuropsychological test scores. Patient-centered outcomes. Future trials should measure independence, functional recovery, and quality of life, not just neuropsychological test scores. Conclusion Perioperative neurocognitive disorders were once considered an inevitable consequence of surgery. They are not. They are preventable, modifiable, and measurable. Anesthesiology stands at a crossroads: we can either allow perioperative NCD to persist as an underdiagnosed burden, or we can lead the way in protecting cognitive health. The past teaches us humility, the present shows us the gaps, and the future offers tools we must seize. Our patients deserve not only safe anesthesia, but also the preservation of the very essence of who they are. Acknowledgments None. Declaration of generative AI in scientific writing During the preparation of this work the authors used ChatGPT 4.0 to improve readability. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. Authors’ contributions SS; TS: Substantial contribution to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for important intellectual content. YW: Contributed to drafting and revising the article. All authors have read and approved the final manuscript; and agree to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Funding None. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.